This is a preview of subscription content, log in via an institution to check access.
Reference
Biskupiak J, et al. Cost implications of formulary decisions on oral anticoagulants in nonvalvular atrial fibrillation. Journal of Managed Care Pharmacy 19: 789-98, No. 9, Nov 2013. Available from: URL: http://dx.doi.org/2013(19)9:789-798 [pii]
Rights and permissions
About this article
Cite this article
Considering cost implications of anticoagulants in AF. PharmacoEcon Outcomes News 691, 6 (2013). https://doi.org/10.1007/s40274-013-0862-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0862-z